Tiotropium bromide is associated with possible increased risk of stroke
The long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) with Boehringer Ingelheim's
Targeted Drug Combination Reveals New Activity in Brain Tumors
December 28th 2021A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.